U.S. lawmakers push Mylan, Teva over drug pricing probe -statement

The head of the U.S. House of Representative's oversight panel on Wednesday called on three drugmakers to turn over documents as part of an ongoing congressional review over generic drug price increases and accused the companies of "apparent efforts to stonewall" the probe.

U.S. House Oversight Chairman Elijah Cummings, along with U.S. Senator Bernie Sanders, the ranking member on the Senate Budget Committee, sent the letters to Mylan NV, Teva Pharmaceutical Industries Ltd, and privately held Heritage Pharmaceuticals, the lawmakers said in a statement.

Also Read: Rugby: Preparations for Zambia game underway ahead of Victoria Cup in Uganda